![Cancers | Free Full-Text | PD-1+CD8+ T Cells Proximal to PD-L1+CD68+ Macrophages Are Associated with Poor Prognosis in Pancreatic Ductal Adenocarcinoma Patients Cancers | Free Full-Text | PD-1+CD8+ T Cells Proximal to PD-L1+CD68+ Macrophages Are Associated with Poor Prognosis in Pancreatic Ductal Adenocarcinoma Patients](https://www.mdpi.com/cancers/cancers-15-01389/article_deploy/html/images/cancers-15-01389-g001.png)
Cancers | Free Full-Text | PD-1+CD8+ T Cells Proximal to PD-L1+CD68+ Macrophages Are Associated with Poor Prognosis in Pancreatic Ductal Adenocarcinoma Patients
![Cancers | Free Full-Text | Immunotherapy in Acute Leukemias: Past Success Paves the Way for Future Progress Cancers | Free Full-Text | Immunotherapy in Acute Leukemias: Past Success Paves the Way for Future Progress](https://www.mdpi.com/cancers/cancers-15-04137/article_deploy/html/images/cancers-15-04137-g001.png)
Cancers | Free Full-Text | Immunotherapy in Acute Leukemias: Past Success Paves the Way for Future Progress
![JCM | Free Full-Text | Epithelial Ovarian Cancer and the Immune System: Biology, Interactions, Challenges and Potential Advances for Immunotherapy JCM | Free Full-Text | Epithelial Ovarian Cancer and the Immune System: Biology, Interactions, Challenges and Potential Advances for Immunotherapy](https://www.mdpi.com/jcm/jcm-09-02967/article_deploy/html/images/jcm-09-02967-g001-550.jpg)
JCM | Free Full-Text | Epithelial Ovarian Cancer and the Immune System: Biology, Interactions, Challenges and Potential Advances for Immunotherapy
![Cancers | Free Full-Text | The Implementation of TNFRSF Co-Stimulatory Domains in CAR-T Cells for Optimal Functional Activity Cancers | Free Full-Text | The Implementation of TNFRSF Co-Stimulatory Domains in CAR-T Cells for Optimal Functional Activity](https://www.mdpi.com/cancers/cancers-14-00299/article_deploy/html/images/cancers-14-00299-g001.png)
Cancers | Free Full-Text | The Implementation of TNFRSF Co-Stimulatory Domains in CAR-T Cells for Optimal Functional Activity
![Biomedicines | Free Full-Text | Comparison of CD3e Antibody and CD3e-sZAP Immunotoxin Treatment in Mice Identifies sZAP as the Main Driver of Vascular Leakage Biomedicines | Free Full-Text | Comparison of CD3e Antibody and CD3e-sZAP Immunotoxin Treatment in Mice Identifies sZAP as the Main Driver of Vascular Leakage](https://www.mdpi.com/biomedicines/biomedicines-10-01221/article_deploy/html/images/biomedicines-10-01221-g001.png)
Biomedicines | Free Full-Text | Comparison of CD3e Antibody and CD3e-sZAP Immunotoxin Treatment in Mice Identifies sZAP as the Main Driver of Vascular Leakage
![Determination of T cell subset frequencies within total CD3+ T cells.... | Download Scientific Diagram Determination of T cell subset frequencies within total CD3+ T cells.... | Download Scientific Diagram](https://www.researchgate.net/publication/351641798/figure/fig2/AS:1024637290962946@1621303975759/Determination-of-T-cell-subset-frequencies-within-total-CD3-T-cells-A-Gating-of-T.png)
Determination of T cell subset frequencies within total CD3+ T cells.... | Download Scientific Diagram
![Antibody Therapies for Patients With Diffuse Large B-cell Lymphoma: What Does the Future Hold? - EMJ Antibody Therapies for Patients With Diffuse Large B-cell Lymphoma: What Does the Future Hold? - EMJ](https://www.emjreviews.com/wp-content/uploads/2020/05/feature_image_roche_icml.jpg)
Antibody Therapies for Patients With Diffuse Large B-cell Lymphoma: What Does the Future Hold? - EMJ
![Frontiers | Case Report: Cord blood-derived natural killer cells as new potential immunotherapy drug for solid tumor: a case study for endometrial cancer Frontiers | Case Report: Cord blood-derived natural killer cells as new potential immunotherapy drug for solid tumor: a case study for endometrial cancer](https://www.frontiersin.org/files/Articles/1213161/fimmu-14-1213161-HTML/image_m/fimmu-14-1213161-g001.jpg)
Frontiers | Case Report: Cord blood-derived natural killer cells as new potential immunotherapy drug for solid tumor: a case study for endometrial cancer
![The Impact of Graft CD3 Cell/Regulatory T Cell Ratio on Acute Graft-versus-Host Disease and Post-Transplantation Outcome: A Prospective Multicenter Study of Patients with Acute Leukemia Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation - The Impact of Graft CD3 Cell/Regulatory T Cell Ratio on Acute Graft-versus-Host Disease and Post-Transplantation Outcome: A Prospective Multicenter Study of Patients with Acute Leukemia Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation -](https://www.astctjournal.org/cms/asset/cb3c725c-9b1c-4e2c-9c07-ddc0801a1c28/gr1.jpg)
The Impact of Graft CD3 Cell/Regulatory T Cell Ratio on Acute Graft-versus-Host Disease and Post-Transplantation Outcome: A Prospective Multicenter Study of Patients with Acute Leukemia Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation -
Semiconductor Nanoplatelets: A New Class of Ultrabright Fluorescent Probes for Cytometric and Imaging Applications | ACS Applied Materials & Interfaces
![Frontiers | Spatial distribution of CD3- and CD8-positive lymphocytes as pretest for POLE wild-type in molecular subgroups of endometrial carcinoma Frontiers | Spatial distribution of CD3- and CD8-positive lymphocytes as pretest for POLE wild-type in molecular subgroups of endometrial carcinoma](https://www.frontiersin.org/files/Articles/1110529/fmed-10-1110529-HTML/image_m/fmed-10-1110529-g001.jpg)
Frontiers | Spatial distribution of CD3- and CD8-positive lymphocytes as pretest for POLE wild-type in molecular subgroups of endometrial carcinoma
![IJMS | Free Full-Text | Joining Forces for Cancer Treatment: From “TCR versus CAR” to “TCR and CAR” IJMS | Free Full-Text | Joining Forces for Cancer Treatment: From “TCR versus CAR” to “TCR and CAR”](https://www.mdpi.com/ijms/ijms-23-14563/article_deploy/html/images/ijms-23-14563-g001.png)
IJMS | Free Full-Text | Joining Forces for Cancer Treatment: From “TCR versus CAR” to “TCR and CAR”
![Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL | Leukemia Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL | Leukemia](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41375-023-02010-y/MediaObjects/41375_2023_2010_Fig1_HTML.png)
Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL | Leukemia
![In Pediatric Lymphoblastic Leukemia of B-Cell Origin, a Small Population of Primitive Blast Cells Is Noncycling, Suggesting Them to be Leukemia Stem Cell Candidates | Pediatric Research In Pediatric Lymphoblastic Leukemia of B-Cell Origin, a Small Population of Primitive Blast Cells Is Noncycling, Suggesting Them to be Leukemia Stem Cell Candidates | Pediatric Research](https://media.springernature.com/full/springer-static/image/art%3A10.1203%2FPDR.0b013e3182092716/MediaObjects/41390_2011_Article_BFpr9201138_Fig1_HTML.jpg)
In Pediatric Lymphoblastic Leukemia of B-Cell Origin, a Small Population of Primitive Blast Cells Is Noncycling, Suggesting Them to be Leukemia Stem Cell Candidates | Pediatric Research
![IJMS | Free Full-Text | Cord Blood T Cells Expressing High and Low PKCζ Levels Develop into Cells with a Propensity to Display Th1 and Th9 Cytokine Profiles, Respectively IJMS | Free Full-Text | Cord Blood T Cells Expressing High and Low PKCζ Levels Develop into Cells with a Propensity to Display Th1 and Th9 Cytokine Profiles, Respectively](https://www.mdpi.com/ijms/ijms-22-04907/article_deploy/html/images/ijms-22-04907-g001.png)
IJMS | Free Full-Text | Cord Blood T Cells Expressing High and Low PKCζ Levels Develop into Cells with a Propensity to Display Th1 and Th9 Cytokine Profiles, Respectively
![Frontiers | A novel trivalent non-Fc anti-CD3 Collabody preferentially induces Th1 cell apoptosis in vitro and long-lasting remission in recent-onset diabetic NOD mice Frontiers | A novel trivalent non-Fc anti-CD3 Collabody preferentially induces Th1 cell apoptosis in vitro and long-lasting remission in recent-onset diabetic NOD mice](https://www.frontiersin.org/files/MyHome%20Article%20Library/1201853/1201853_Thumb_400.jpg)
Frontiers | A novel trivalent non-Fc anti-CD3 Collabody preferentially induces Th1 cell apoptosis in vitro and long-lasting remission in recent-onset diabetic NOD mice
![Pharmaceuticals | Free Full-Text | T Cell Bispecific Antibodies: An Antibody-Based Delivery System for Inducing Antitumor Immunity Pharmaceuticals | Free Full-Text | T Cell Bispecific Antibodies: An Antibody-Based Delivery System for Inducing Antitumor Immunity](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-14-01172/article_deploy/html/images/pharmaceuticals-14-01172-g001.png)